DONOSIMO BILTEN MDS FOUNDATION-A ZA TRAVANJ 2023. GODINE - 21. TRAVANJ SVJETSKI JE DAN AKUTNE MIJELOIČNE LEUKEMIJE

Akutna mijeloična leukemija (AML) je rak krvi i koštane srži. AML je najčešća akutna leukemija koja pogađa odrasle osobe, s oko 20 000 novih slučajeva dijagnosticiranih svake godine. MDS (mijelodisplastični sindrom) napreduje u AML u otprilike 30% bolesnika.

Vaš rizik od razvoja AML-a uvelike ovisi o tome koji podtip MDS-a imate u vrijeme dijagnoze. Posljednjih godina napravljen je veliki napredak u razumijevanju genomskog krajolika AML-a i kako najbolje liječiti ovaj rijetki rak.

Više o svemu pročitajte na linkovima iz biltena (newslettera) u nastavku.
 
Dražen Vincek
 
View this email in your browser
 

Acute Myeloid Leukemia (AML) is a cancer of the blood and bone marrow. AML is the most common acute leukemia affecting adults, with about 20,000 new cases diagnosed each year. MDS progresses to AML in approximately 30% of patients. The risk of developing AML depends largely on which MDS subtype you have at the time of diagnosis. Huge breakthroughs have been made in recent years in regard to understanding the genomic landscape for AML and how to best manage this rare cancer.

The MDS Foundation is proud to be a patient advocacy ambassador member of the KNOW AML Coalition, a collective of AML patient leaders, professional, and industry representatives. If you are affected or know someone affected by AML, you are not alone. Visit know-aml.com and the MDS Foundation for further in-depth information on AML.

Let’s unite and join the global effort to raise the awareness of Acute Myeloid Leukemia on AML World Awareness Day!
 

You and AML: An Animated Patient’s Guide to Acute Myeloid Leukemia

 
This resource is intended for patients with acute myeloid leukemia (AML). You will find expert advice about AML, AML with myelodysplasia-related changes (AML-MRC) and treatment-related AML (tAML) to help you discuss key issues with your healthcare provider and make important decisions related to management and treatment.
 
“You and AML” contains 4 learning modules:
  1. Understanding AML
  2. Understanding AML-MRC and tAML
  3. Diagnosing AML, AML-MRC and tAML
  4. Treatment of AML
Each module contains easy-to-understand animations with audio narration, video explanations by AML experts, patient interviews, and illustrated slide shows.
 
This webinar will not be recorded. 
Register here
 
 
 

Facebook
Twitter
Website
Email
LinkedIn
Instagram

Podijeli

Zagreb, HR
2°C
blaga naoblaka

Hrvatska udruga leukemija i limfomi
predsjednik Dražen Vincek
Trg hrvatskih velikana 2/ll
10 000 Zagreb
OIB:51774844072
MB: 01136763
REG. BR.: 00000797
GSM: +385 (0)91 4873 561
TEL: +385 (0)1 4873 561
e-mail: udruga.hull.zagreb@gmail.com
Web adresa: www.hull.hr
IBAN: HR 36 2340 0091 1100 4711 4
SWIFT CODE: PBZGHR2X

Važni datumi

prosinac 2023

NedPonUtoSriČetPetSub

1


2


3


4


5


6


7


8


9


10


11


12


13


14


15


16


17


18


19


20


21


22


23


24


25


26


27


28


29


30


31


Health through Knowledge

Klasa optimist

Igor Delač- Samo zbog vas

(Ivan Zečić/Miroslav Zečić – Miroslav Zečić/Ivan Zečić) ℗ 2021 Croatia Records

Istaknuti sponzori HULL-a